Moxifloxacin-induced Abducens Nerve Palsy: A Rare Neurological Complication During Mycobacterium avium Complex Lung Disease Treatment
Abstract
Mycobacterium avium complex (MAC) lung disease requires prolonged multidrug therapy. We report the case of an 80-year-old woman with MAC lung disease who developed an isolated right abducens nerve palsy after approximately nine months of treatment with moxifloxacin, azithromycin, and ethambutol. The patient presented with horizontal diplopia, and ophthalmological evaluation confirmed sixth cranial nerve palsy. Although ethambutol-induced optic neuropathy was initially considered, clinical findings were not consistent with this diagnosis. Given the temporal relationship with moxifloxacin exposure and the absence of other identifiable etiologies, fluoroquinolone-induced neurotoxicity was considered the most likely cause. Partial improvement was observed during follow-up. This case highlights a probable rare neurological complication of moxifloxacin and the importance of considering drug-related cranial neuropathies in patients receiving prolonged treatment for MAC lung disease.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.